Request availability and a quotation for your required quantity and destination.
| Product | Sulfamethoxazole 800 mg + Trimethoprim 160 mg - Co-trimoxazole Tablets |
|---|---|
| Categories | Urinary Tract Infection (UTI) |
| Pack Size | 60 Tablets, 120 Tablets, 180 Tablets |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Category: Urinary Tract Infection (UTI)
Dosage form: Oral prescription tablet
Pack sizes: 60 Tablets, 120 Tablets, 180 Tablets
Co-trimoxazole combines sulfamethoxazole and trimethoprim in a double-strength 800 mg/160 mg tablet. It is used for specified infections caused by susceptible organisms, including some urinary tract infections, and for treatment or prevention of Pneumocystis jirovecii pneumonia in appropriate patients. Choice depends on local resistance, diagnosis and individual risk.
The two ingredients inhibit sequential steps in bacterial folate synthesis, producing combined antibacterial activity.
Antibiotic selection should be based on symptoms, clinical assessment, susceptibility testing where appropriate, past history, kidney function and current prescribing guidance. Never use antibiotics for unrelated or unproven conditions. Follow the prescribed course and seek help for fever, flank pain or worsening symptoms.
Serious adverse reactions include severe cutaneous reactions such as Stevens–Johnson syndrome, blood disorders, liver injury, hyperkalemia and kidney-related complications. Sulfonamide allergy and important interactions must be reviewed. Potassium monitoring may be necessary with kidney disease or interacting medicines.
It treats selected susceptible bacterial infections and is used for certain Pneumocystis infections under clinical supervision.
Yes, when the causative bacteria are susceptible and the antibiotic is suitable for the patient.
No. This formulation includes sulfamethoxazole plus trimethoprim.
A history of sulfonamide allergy is a major contraindication and must be discussed with a clinician.
Yes. Trimethoprim can cause hyperkalemia, especially with kidney impairment or interacting drugs.
Yes. New rash, blisters, fever or mouth lesions require urgent medical assessment.
Kidney function and blood tests may be necessary depending on dose, duration and patient history.
Yes. It can increase warfarin effects and bleeding risk; prescriber monitoring is required.
Potential fetal risks require clinician assessment; do not self-prescribe during pregnancy.
Seek reassessment for resistance, alternative diagnoses or kidney involvement rather than repeating antibiotics without evaluation.
Cureiva Healthcare handles lawful product enquiries subject to prescription requirements, manufacturer verification, and import rules. This page is educational, not a substitute for medical advice or a claim of individual physician review.